Načítá se...
Targeting the programmed cell death-1 pathway in rheumatoid arthritis
Since the introduction of TNF-α inhibitors and other biologic agents, the clinical outcome for many treated rheumatoid arthritis patients has significantly improved. However, there are still a substantial proportion of patients that are intolerant, or have inadequate responses, with current agents t...
Uloženo v:
| Vydáno v: | Autoimmun Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5596871/ https://ncbi.nlm.nih.gov/pubmed/28572054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.autrev.2017.05.025 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|